Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 47.78 | 22.06 |
| PEG Ratio (TTM) | -2.07 | 0.33 |
| P/S Ratio (TTM) | 0.46 | 1.22 |
| P/B Ratio (TTM) | 1.65 | 4.63 |
| P/FCF Ratio (TTM) | 20.13 | 25.30 |
| Price to 5YR AVG Earnings Ratio | N/A | 19.16 |
| Price to 5YR AVG FCF Ratio | N/A | 33.42 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.90% | 6.82% |
| ROE (TTM) | 3.63% | 23.17% |
| Net Profit Margin (TTM) | 0.97% | 5.63% |
| ROIC 5YR AVG | N/A | 23.78% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.70% | 218.42% | N/A |
| Revenue | 6.61% | 10.10% | N/A |
| Net Income | 12.37% | 228.00% | N/A |
| Cash Flow | 28.48% | 36.53% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.86 | 1.22 |
| Quick Ratio (TTM) | 0.86 | 1.20 |
| D/E Ratio (TTM) | 0.83 | 0.85 |
| Interest Coverage (TTM) | 2.02 | 19.16 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 1.38 | 3.75 |
| LTL to 5YR AVG FCF | N/A | 8.82 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.79% |